Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol versus ketamine infusion for sedation during upper gastrointestinal endoscopy
IRCT20250615066195N1Phase 3Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Jul 2025
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of propofol, ketamine and fentanyl (2 arms), sponsored by Babol University of Medical Sciences. Primary endpoints: Hemodynamic changes during upper gastrointestinal endoscopy, Mean arterial pressure and 3 more. Started Jul 2025; status: completed.
02
Drugs
propofolketaminefentanyl
Beyond the preview
Go deeper on IRCT20250615066195N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250615066195N1.